Kim and co-workers has recently presented a study which demonstrated an increase in
urinary 8-isoprostoglandin levels in patients with Graves’ hyperthyroidism [
[1]
]. They suggested that urinary 8-isoprostoglandin can be used as a biomarker in hyperthyroid patients.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Prostaglandins, Leukotrienes and Essential Fatty AcidsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Elevated urinary 8-isoprostoglandin F2α in females with Graves’ hyperthyroidism.Prostoglandins Leukot. Essent. Fatty Acids. 2004; 71: 143-147
- Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane).Thromb. Res. 2000; 99: 209-221
- Increased plasma, serum and urinary 8-epi-prostoglandin F2 in heterozygous hypercholesterolemia.Wien Klin. Wochenschr. 1999; 111: 113-118
- Cyclooxygenase-dependent thyroid cell proliferation induced immunoglubulins from patients with Graves’ disease.J. Clin. Endocrinol. Metab. 1997; 82: 670-673
- Radioiodine therapy induces dose-dependent in vivo oxidation injury.J. Nucl. Med. 2002; 43: 1254-1258
- Prostoglandins as biochemical markers of radiation injury to salivary glands after iodine-131 therapy?.Eur. J. Nucl. Med. 1998; 25: 265-269
Article info
Publication history
Published online: September 22, 2004
Identification
Copyright
© 2004 Elsevier Ltd. Published by Elsevier Inc. All rights reserved.
